MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway
about
The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancerWnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approachesDecreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway.MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer.Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity.LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma.WNT signaling - lung cancer is no exception.MicroRNA-410 promotes chondrogenic differentiation of human bone marrow mesenchymal stem cells through down-regulating Wnt3aHigh expression of SLC34A2 is a favorable prognostic marker in lung adenocarcinoma patients.Human umbilical cord mesenchymal stem cell-derived extracellular vesicles promote lung adenocarcinoma growth by transferring miR-410.Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.TRIM44, a crucial target of miR-410, functions as a potential oncogene in osteosarcoma.
P2860
Q28076568-2D98E01B-517A-4B02-B0AE-25BD0E62F41DQ28077396-67399601-7639-420C-92E1-72B270A5D588Q37602508-CC0742E8-19F6-4967-95D6-87B4A85EC1FAQ37706915-F9EDD884-7C58-43B8-B707-20DCF0ED353DQ37745154-0ACA509E-1658-4034-B02D-402DC001C0D7Q41169814-BE31D091-EF9D-4B54-9C89-C95BABBF1FB9Q41613396-DF97EE64-0F38-4ACC-8BDA-50710BF8FC0CQ42108123-85047F09-F48B-4570-90BA-641CE671645AQ47829530-4C97F014-D67D-4341-A973-27EB1C1879A4Q50025868-2D0C0000-CDA9-4E78-9367-88A10ACF67C7Q52715797-5DCCBCEF-C9D1-43E8-8319-BA7B1C2DC9B5Q55419711-06F57077-1EB8-4307-95F9-D6C37BB6E900
P2860
MicroRNA-410 acts as oncogene in NSCLC through downregulating SLC34A2 via activating Wnt/β-catenin pathway
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA-410 acts as oncogene ...... tivating Wnt/β-catenin pathway
@en
MicroRNA-410 acts as oncogene ...... ivating Wnt/β-catenin pathway.
@nl
type
label
MicroRNA-410 acts as oncogene ...... tivating Wnt/β-catenin pathway
@en
MicroRNA-410 acts as oncogene ...... ivating Wnt/β-catenin pathway.
@nl
prefLabel
MicroRNA-410 acts as oncogene ...... tivating Wnt/β-catenin pathway
@en
MicroRNA-410 acts as oncogene ...... ivating Wnt/β-catenin pathway.
@nl
P2093
P2860
P356
P1433
P1476
MicroRNA-410 acts as oncogene ...... tivating Wnt/β-catenin pathway
@en
P2093
Qianqian Jiang
Weihan Yang
Xiaolan Su
Xinmei Luo
Xuechao Zhang
P2860
P304
14569-14585
P356
10.18632/ONCOTARGET.7538
P407
P577
2016-02-20T00:00:00Z